Top Markets
Coin of the day
Oxurion N.V. Oxurion N.V.

Oxurion N.V.

OXUR
Rank in Stocks #39566
Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a... Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a biopharmaceutical firm focused on researching, developing, and bringing to market treatments for various ocular conditions worldwide. Its primary commercialized offering is JETREA, a medication used to address vitreomacular adhesion and vitreomacular traction. The company's development pipeline includes THR-149, a plasma kallikrein inhibitor currently undergoing Phase II clinical trials for diabetic macular edema (DME), and THR-687, an integrin antagonist also in Phase II trials for DME. Oxurion has forged strategic partnerships with Bicycle Therapeutics, INC Research, and Galapagos NV. The organization was formerly known as ThromboGenics NV before officially changing its name to Oxurion NV in September 2018.
Share Price
$0.003084
Market Cap
$434.03K
Change (1 day)
-7.14%
Change (1 year)
-89.24%
Country
BE
Trade Oxurion N.V. (OXUR)

Category

Stock price history for Oxurion N.V. (OXUR)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $62.97K on 2006-07-01
Stock price history of Oxurion N.V. from 2006 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 5.23%
2025 -96.55%
2024 -97.10%
2023 -94.05%
2022 -99.22%
2021 -35.88%
2020 10.67%
2019 -29.09%
2018 -4.13%
2017 62.47%
2016 -25.93%
2015 -55.06%
2014 -66.50%
2013 -54.24%
2012 123.36%
2011 -17.09%
2010 25.57%
2009 132.05%
2008 -27.90%
2007 10.78%
2006 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$517.18 32.51%
US
$857.76 31.47%
NL
$731.17 7.05%
CH
$1.07K -6.40%
KR
$257.40 13.71%
BE